Risk factors and antibiotic therapy in P. aeruginosa community‐acquired pneumonia

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1843|20|4|660-666

ISSN： 1323-7799

Source： RESPIROLOGY (ELECTRONIC), Vol.20, Iss.4, 2015-05, pp. : 660-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The risk factors for mortality of community-acquired pneumonia in Japan

By Fujiki Rei   Kawayama Tomotaka   Ueyama Toshihiko   Ichiki Masao   Aizawa Hisamichi  

Journal of Infection and Chemotherapy, Vol. 13, Iss. 3, 2007-06 ,pp. : 157-165

Springer Publishing Company

Access to resources Recommend Favorite

Antibiotic therapy for inpatients with community‐acquired pneumonia in a developing country

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. : 129-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibiotic treatment for children hospitalized with community‐acquired pneumonia after oral therapy

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 5, 2015-05 ,pp. : 495-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies

By  

Respiration, Vol. 94, Iss. 3, 2017-07 ,pp. : 299-311

Karger

Access to resources Recommend Favorite

Community‐acquired pneumonia: why aren't national antibiotic guidelines followed?

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 2, 2015-02 ,pp. : 259-266

John Wiley & Sons Inc

Access to resources Recommend Favorite